Roberto Prado

Dr. Roberto Prado

BTI Biotechnology Institute, Vitoria-Gasteiz, Basque Country, Spain
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2009 in Cell Proliferation
Verified
Journal Article
Closed access
EAEduardo Anitua
Eduardo Anitua
MSM. Sánchez
M. Sánchez
MZM. M. Zalduendo
M. M. Zalduendo
MFMaría de la Fuente
María de la Fuente
RPRoberto Prado
Roberto Prado
IAIsabel Andia
Isabel Andia

18 January 2010 in Arthroscopy
Verified
Journal Article
Closed access
MSMikel Sánchez
Mikel Sánchez
EAEduardo Anitua
Eduardo Anitua
JAJuan Azofra
Juan Azofra
RPRoberto Prado
Roberto Prado
FMFrancisco Muruzabal
Francisco Muruzabal
IAIsabel Andia
Isabel Andia

20 November 2016 in Expert Opinion on Biological Therapy
Verified
Journal Article
Closed access
MSMikel Sánchez
Mikel Sánchez
EAEduardo Anitua
Eduardo Anitua
DDDiego Delgado
Diego Delgado
PSPeio Sanchez
Peio Sanchez
RPRoberto Prado
Roberto Prado
SPSabino Padilla
Sabino Padilla
Introduction: In mammals, axons of injured peripheral nerves (PNI) can and do regenerate, but often the functional recovery is incomplete or suboptimal. In recent years, in vivo tissue engineering approaches through molecular intervention and scaffolding are offering promising outcomes. Evidence is accumulating in both preclinical and clinical settings indicating that Platelet-rich plasma (PRP) and fibrin scaffolds obtained from this technology hold an important adjuvant therapeutic potential. Areas covered: This review addresses current molecular and cellular data in intrinsic nerve repair processes and describes different strategies to harness and enhance these processes by using biochemical and biomechanical cues. It focuses on autologous fibrin, plasma and platelet-derived growth factors as filler or scaffolds that can synergize with the gold standard therapy and other nerve guidance conduits. Expert opinion: PRP is applied as a filler of nerve conduits or vein-muscle grafts across nerve gaps post trauma by infiltrating the nerve stumps perineurally and intraneurally in neuropathies, or as scaffolds to bridge or wrap nerve stumps, with significant neurological recovery and pain reduction. The application of PRP at the injured nerve site might be considered as an ‘off the shelf’ alternative.

2 June 2014 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
EAEduardo Anitua
Eduardo Anitua
MZM. M. Zalduendo
M. M. Zalduendo
RPRoberto Prado
Roberto Prado
MAMohammad Alkhraisat
Mohammad Alkhraisat
GOGorka Orive
Gorka Orive

1 March 2012 in Operative Techniques in Orthopaedics
Verified
Journal Article
Closed access
EAEduardo Anitua
Eduardo Anitua
RPRoberto Prado
Roberto Prado
MSMikel Sánchez
Mikel Sánchez
GOGorka Orive
Gorka Orive

18 March 2013 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
EAEduardo Anitua
Eduardo Anitua
RPRoberto Prado
Roberto Prado
MAMikel Azkargorta
Mikel Azkargorta
EREva Rodriguez-Suárez
Eva Rodriguez-Suárez
IIIbon Iloro
Ibon Iloro
GOGorka Orive
Gorka Orive
Plasma rich in growth factors (PRGF®-Endoret®) is an autologous technology that contains a set of proteins specifically addressed to wound healing and tissue regeneration. The scaffold formed by using this technology is a clot mainly composed of fibrin protein, forming a three-dimensional (3D) macroscopic network. This biomaterial is easily obtained by biotechnological means from blood and can be used in a range of situations to help wound healing and tissue regeneration. Although the main constituent of this clot is the fibrin scaffold, little is known about other proteins interacting in this clot that may act as adjuvants in the healing process. The aim of this study was to characterize the proteins enclosed by PRGF–Endoret scaffold, using a double-proteomic approach that combines 1D-SDS–PAGE approach followed by LC–MS/MS, and 2-DE followed by MALDI–TOF/TOF. The results presented here provide a description of the catalogue of key proteins in close contact with the fibrin scaffold. The obtained lists of proteins were grouped into families and networks according to gene ontology. Taken together, an enrichment of both proteins and protein families specifically involved in tissue regeneration and wound healing has been found. Copyright © 2013 John Wiley & Sons, Ltd.